Archive for the ‘vaccines’ Category

Polio-like Disease Expected To Increase This Fall

Please read up on the chronology of Polio and the fact 95% of people who contract it have ZERO symptoms.  There is also a 38 times increased risk of permanent injury from the IPV vaccine than from the infection itself.

Please see comment after article on how AFM has been associated with Lyme/MSIDS.

https://articles.mercola.com/sites/articles/archive/2019/07/23/acute-flaccid-myelitis-polio-like-disease.aspx?

Polio-like disease expected to increase this fall

Analysis by Dr. Joseph MercolaFact Checked
acute flaccid myelitis polio like disease

STORY AT-A-GLANCE

  • While the global polio eradication effort appears to have been successful, routine vaccination may simply have replaced one disease with another
  • U.S. Centers for Disease Control and Prevention is urging health care professionals to be on the lookout for cases of acute flaccid myelitis (AFM) — a polio-like disease that first drew the agency’s attention in 2014
  • Outbreaks of AFM have been recorded on a biennial basis, with spikes occurring in 2014, 2016 and 2018. While symptoms mimic those of paralytic polio, investigations have failed to find the poliovirus in any of the confirmed cases of AFM. At present, the enterovirus D68 is a top suspect in AFM
  • For decades, it’s been known that under certain conditions a phenomenon referred to as “provocation polio” can occur after injections, including injections of vaccines. Yet this issue is being largely, if not entirely, ignored in today’s discussions about AFM

Polio (poliomyelitis) is a very contagious enterovirus infection that usually causes mild flu-like symptoms or no symptoms at all, and most people recover from polio without lasting health problems (nonparalytic polio).1

However, severe complications of polio can cause partial or total body paralysis, breathing difficulties and death.2 The first clinical description of this contagious disease was given by Michael Underwood, a British doctor, in 1789. The first recorded outbreak of polio in the U.S. occurred in Vermont in 1894.3

As noted by the Polio Eradication Initiative,

“In the early 20th century, polio was one of the most feared diseases in industrialized countries, paralyzing hundreds of thousands of children every year.”4According to the U.S. Centers for Disease Control, “In the early 1950s, before polio vaccines were available, polio outbreaks caused more than 15,000 cases of paralysis each year in the United States.”5

Dr. Jonas Salk began studying polio in 1947, and in the mid-1950s developed the first inactivated injectable polio vaccine (IAV).6,7 A live attenuated oral polio vaccine (OPV) was developed in the early 1960s, and quickly became the vaccine of choice around the globe.8

During the 1970s and ’80s, routine use of OPV for child vaccination programs was adopted by countries around the world and, in 1988, the World Health Assembly passed a resolution to eradicate polio by 2000. The last known case of wild type polio in the Western Hemisphere is believed to have occurred in Peru in 1991.9,10

The live attenuated polio vaccine can cause vaccine strain polio paralysis in the person vaccinated or someone who comes into contact with the body fluids (urine, stool, saliva) of a recently vaccinated person shedding vaccine strain polio virus.11

It wasn’t until 1999 that U.S. public health officials switched from recommending universal use of live OPV and started recommending the use of inactivated polio vaccine (IVP) again, “to eliminate the risk for vaccine-associated paralytic poliomyelitis.”12

Vaccine-derived polio on the rise

While the global poliovirus eradication effort appears to have been successful, the consequences of routine use of OPV are not fully known. In 2009, the World Health Organization warned that live polio vaccine may be responsible for a rise in vaccine strain polio termed Vaccine Derived Polio Disease (VDPD).13,14

Not only has live vaccine strain poliovirus been found to cause paralytic disease in some cases, but evidence also shows that mutated vaccine-derived viruses are responsible for some outbreaks.15,16 As reported by NPR in 2017:17

“For the first time, the number of children paralyzed by mutant strains of the polio vaccine are greater than the number of children paralyzed by polio itself. So far in 2017, there have been only six cases of ‘wild’ polio reported anywhere in the world …

By contrast, there have been 21 cases of vaccine-derived polio this year. These cases look remarkably similar to regular polio. But laboratory tests show they’re caused by remnants of the oral polio vaccine that have gotten loose in the environment, mutated and regained their ability to paralyze unvaccinated children

‘It’s actually an interesting conundrum. The very tool you are using for [polio] eradication is causing the problem,’ says Raul Andino, a professor of microbiology at the University of California at San Francisco.”

A year later, as further evidence that VDPD is still frustrating public health officials, the Polio Global Eradication Initiative reported that worldwide in 2018 there were 104 confirmed cases of VDPV — and only 33 cases of wild poliovirus.18


We may be going from bad to worse

A 2016 study19 in the Journal of Virology highlighted the very real problems that human populations face from mutated vaccine-derived polioviruses:

“Until this outbreak, Sabin-like viruses (in distinction to more markedly evolved vaccine-derived polioviruses [VDPVs]) were reported to cause only sporadic cases of VAPP [vaccine-associated paralytic poliomyelitis]. Consequently, VAPP cases were not considered to require outbreak-type responses.

However, the Biysk outbreak completely blurred the borderline between Sabin-like viruses and VDPVs in epidemiological terms. The outbreak demonstrated a very high disease/infection ratio, apparently exceeding even that reported for wild polioviruses.

The viral genome structures did not provide any substantial hints as to the underlying reason(s) for such pathogenicity … Altogether, the results demonstrate several new aspects of pathogenicity, epidemiology, and evolution of vaccine-related polioviruses and underscore several serious gaps in understanding these problems.”

CDC warns polio-like disease is spreading

In 2009, WHO20 urged enhanced surveillance for acute flaccid paralysis (AFP), of which one known cause is paralysis from wild type or vaccine strain polio.21 In October 2018, the Washington State Department of Health issued a 23-page Acute Flaccid Myelitis and Poliomyelitis Reporting and Investigation Guideline.22

The guidelines advised doctors about how to conduct a routine investigation of suspected cases of Acute Flaccid Myelitis (AFM), a polio-liked disease, as well as suspected cases of wild type or vaccine strain polio:

“Any person noted to have AFM has the potential to be a polio case. Immediately obtaining information about prior immunizations and recent travel or exposure to a recent OPV vaccinee is extremely important for every suspect AFM case.”

In evaluating and determining the likelihood of a diagnosis, public health officials directed doctors to:

Review the clinical presentation, physical exam findings (particularly flaccid weakness).
Review immunization history and risk factors for infection (e.g., recent travel to a polio endemic area or possible exposure to a person that recently received oral polio vaccine).
Obtain history of any recent viral respiratory and/or gastrointestinal illness.
Confirm that clinical criteria including CSF findings and/or MRI test results are met for AFM cases.
If pursuit of laboratory testing is indicated, facilitate timely collection of appropriate specimens and expedite transport of those specimens to PHL.
If a commercial laboratory isolates polio virus in cell culture, request that the laboratory send the cell culture to PHL for confirmatory testing immediately.

State health officials also advised that:

“For a suspected polio case, contacts must be identified and monitored for symptoms. Collection of stool and serum samples from household members and other contacts associated with possible transmission settings may be required. For a confirmed polio case, vaccination should be offered to susceptible contacts with an emphasis on persons who have an ongoing risk of exposure.”

July 9, 2019, the CDC issued a call for increased paralytic disease surveillance,23,24 urging health care professionals to be on the lookout for cases of AFM, which first drew the agency’s attention in 2014. Cases of AFM have been increasing in the U.S., but the CDC maintains the cause is still unknown.

As described by the Cleveland Clinic,25 AFM “is characterized by muscle weakness and myelitis of the spinal cord’s anterior horn cells following a viral illness.” The disease affects primarily children. During the 2018 outbreak in the U.S., the median age of confirmed cases was 5.3 years.26 As for its diagnosis, the Cleveland Clinic says:

“Children with AFM typically present with acute onset of asymmetric flaccid paralysis, often rapidly progressing from normal strength to flaccid weakness with loss of reflexes within hours to a few days. A prodromal illness (typically febrile with respiratory symptoms) a few days prior to the onset of flaccid paralysis is common.

Perplexingly, the respiratory symptoms of the prodromal illness are frequently shared by sick contacts within the household, but they are spared any signs or symptoms of AFM. Patients also frequently report pain in the affected limb at the time of weakness onset.

There does not appear to be any ethnic or racial predispositions, pre-existing comorbidities that place these healthy children at increased risk or any association with vaccination status …

Current Centers for Disease Control and Prevention (CDC) definitions for AFM require two criteria: acute onset of flaccid limb weakness and MRI evidence of a gray matter lesion spanning one or more spinal segments.“

According to the CDC, outbreaks of AFM have been recorded on a biennial basis since then, with spikes occurring in 2014, 2016 and 2018.27 While the symptoms of AFM mimic those caused by poliovirus, investigations have failed to find the poliovirus in any of the confirmed cases of AFM that were lab tested. The CDC stated in its July 2019 report that “Stool specimens from all patients with available specimens tested negative for poliovirus,” while also acknowledging that:28

“Timing of respiratory specimen collection improved in 2018 compared with that in 2016, but still occurred a median of approximately three days after the onset of limb weakness and five days after the onset of any respiratory illness. Shedding of viruses in the respiratory tract can be transient, so delays in specimen collection could contribute to negative findings.”

Mutated enterovirus D68 may be responsible

At present, other enteroviruses, especially coxsackievirus A16, enterovirus A71 and enterovirus D68, are suspected of being responsible for AFM.29

The AFM outbreak in 2014 in the U.S. occurred concurrently with an outbreak of EV-D68,30 a pathogen known to cause respiratory illness. A 2018 paper31 in Frontiers in Microbiology, “Enterovirus D68 — The New Polio?” highlights evidence identifying EV-D68 as a probable cause of AFM.

“The EV-D68 storyline shows many similarities with poliovirus a century ago, stimulating discussion about whether EV-D68 could be ascertaining itself as the ‘new polio,'” the paper states.32

The authors also cite research showing EV-D68 has undergone genetic alterations “known to affect the translational efficiency and thought to increase the virulence.” However, EV-D68 is only found in about half of all cases. Testing of samples taken during the 2014 AFM outbreak revealed EV-D68 in 47% of the samples collected within seven days of disease onset.33

Another study34 found the virus in 48% of respiratory samples collected from AFM patients. However, as noted in The Atlantic,35 the lack of active EV-D68 infection doesn’t mean the virus cannot be the trigger of AFM:

“In many neurological infections, the worst symptoms aren’t caused by the virus itself, but by the body’s disproportionate immune response. That response can continue even after the virus has been cleared, which means that patients often test negative for whatever first triggered their illness.

All the researchers I spoke to think AFM likely behaves in this way, especially since there can be a seven-day gap between the condition’s initial coldlike symptoms and the severe paralytic ones.

By the time parents seek medical help, their children could be suffering from their body’s misplaced attempts to fight an enemy that’s no longer there.”

The ignored vaccine-paralysis link

However, while researchers are trying to pin down the viral cause, there may be something else going on here. For decades, it’s been known that injections, including injections of vaccines, sometimes can cause paralysis under certain conditions — a phenomenon referred to as “provocation polio.” Yet this issue is being largely, if not entirely, ignored in today’s discussions about AFM.

In response to the 2016 BMJ article36 “Conflicts of Interest Compromise U.S. Public Health Agency’s Mission,” Allan S. Cunningham, a retired pediatrician, questioned whether Americans can “trust the CDC to honestly investigate the current AFM outbreak”37 specifically. In his response, Cunningham points out how the CDC is avoiding the well-recognized link between injections and paralytic disease:

“Antecedent injections have been suggested as possible co-factors by clinician-scientists who remember ‘provocation paralysis;’ Hill and Knowelden, for example, found a 20-fold risk of paralytic polio in children who received the DTP shot during the 1949 British polio epidemic …

During the 1990s the NEJM published a study in Romania linking vaccine-associated paralytic polio (VAPP) to penicillin injections. Tissue studies have shown how muscle damage by an injection can provide a portal of entry to the CNS for neurotropic viruses.“

Cunningham describes a conversation he said he had with an unnamed public health official about the 2016 AFM outbreak in Washington State, alleging the health official was aware of the provocation paralysis theory but was “wary of anti-vaccine forces who would misuse data suggesting a serious adverse effect of vaccinations,” and that “for this reason he indicated that statistical details of the CDC’s investigation would not be released to the news media.”

“The CDC, the AAP and many public health officials are afraid that any bad news about vaccines will cause the public to turn away from life-saving vaccines,” Cunningham writes.

“Along with the manufacturers, they are also afraid of the effect such news might have on incomes and careers. Will the CDC do an unbiased, thorough and transparent investigation of the current AFM outbreak?“

Similarly, in a November 2016 article,38 Marcella Piper-Terry, a biomedical consultant and founder of VaxTruth.org, pointed out that AFM following routine childhood vaccination is “nothing new.” “The connection between childhood vaccination and provocation paralysis has been known since the polio outbreaks in the 1940s and 1950s,” she wrote.

The history of provocation polio

Indeed, the 2014 Lancet paper,39 “Polio Provocation: Solving a Mystery with the Help of History,” by Stephen Mawdsley, recounted this history, observing that “Evidence of this correlation was first published by German doctors, who noted that children who had received treatment for congenital syphilis later became paralyzed in the injected limb.”

French and Italian studies corroborated the link between injections of DPT vaccine and provocation polio paralysis, Mawdsley stated, and by the end of World War II, “injection-induced polio emerged as a public health concern.” He explained:40

“The application of epidemiological surveillance and statistical methods enabled researchers to trace the steady rise in polio incidence along with the expansion of immunization programs for diphtheria, pertussis, and tetanus.

A report that emerged from Guy’s and Evelina Hospitals, London, in 1950, found that 17 cases of polio paralysis developed in the limb injected with pertussis or tetanus inoculations.

Results published by Australian doctor Bertram McCloskey also showed a strong association between injections and polio paralysis. Meanwhile, in the USA, public health researchers in New York and Pennsylvania reached similar conclusions. Clinical evidence, derived from across three continents, had established a theory that required attention.”

The mounting scientific evidence that emerged during the 1950s fueled concerns to the point that booster shots were discouraged whenever there was a polio outbreak and “laws mandating pediatric vaccinations before school attendance were relaxed.”41

Immunization practices were also reformed and, according to Mawdsley, “Most health professionals … accepted that seasonal factors and cycles of disease were important to consider before immunizing children.”42

Polio vaccine swept ‘provocation polio’ under the rug

The link between provocation paralysis and vaccine injections quickly receded with the advent of the polio vaccine and mass vaccination programs, however. Mawdsley stated:43

“Once polio vaccination programs established herd immunity among children and adults, the corresponding risk of toxoid-based injections inciting polio paralysis was effectively eliminated.

Orthodox public health and surgical practices were restored. Although medical scientists failed to understand the epidemiological mechanism behind polio provocation, the Salk and Sabin vaccines pushed the issue to the margins of clinical attention.”

Mechanism of injection-induced polio revealed

In the 1990s, scientific advances allowed for a more thorough investigation of the link between vaccine injections and paralysis and, in 1998, the first paper44 describing the actual mechanism of injection-induced polio paralysis was published.

The research, conducted by two State University of New York researchers, Matthias Gromeier and Eckard Wimmer, revealed

“that tissue injury produced by an injection aided the poliovirus to infect the body and readily journey to the spinal cord,” Mawsdley writes, adding “For the first time, health professionals working in polio endemic regions had scientific evidence that pediatric injections could incite paralysis.”

In areas where polio was controlled through vaccination, however, vaccine-induced paralysis “was insignificant,” suggesting the polio vaccine effectively reduced the risk of other vaccinations causing paralytic disease.

A question Mawdsley does not address, however, is how the mutation of vaccine viruses affects this chain of events. We now apparently have vaccine-derived mutated polioviruses that are more virulent than the original poliovirus, and respiratory enteroviruses that are somehow able to trigger paralysis.

Mawdsley does note that concerns about provocation polio resurfaced in the 1980s when routine vaccination programs began to flourish, as the incidence of paralysis again began to rise.

Vaccination also linked to transverse myelitis

According to the Transverse Myelitis Association, AFM is a subtype of transverse myelitis,45 and this condition has also been linked to vaccinations. A 2009 systematic review46 published in the journal Lupus found:

“… 37 reported cases of transverse myelitis associated with different vaccines including those against hepatitis B virus, measles-mumps-rubella, diphtheria-tetanus-pertussis and others, given to infants, children and adults. In most of these reported cases the temporal association was between several days and 3 months, although a longer time frame of up to several years was also suggested.”

Transverse myelitis is also recognized by the U.S. Vaccine Injury Compensation Program (VICP) as a possible injury following receipt of several different types of vaccines.47,48 Piper-Terry writes:49

“In the 1980s, the United States government went on record as choosing the vaccination program over the well-being of children, publishing the following in the Federal Register (the daily journal of the U.S. government), in regard to the polio vaccine:

‘… [A]ny possible doubts, whether or not well founded, about the safety of the vaccine cannot be allowed to exist in view of the need to assure that the vaccine will continue to be used to the maximum extent consistent with the nation’s public health objectives.'”

A PDF copy of that Federal Register article, dated June 1, 1984, can be downloaded at the end of Piper-Terry’s article.50 “We need to scream from the rooftops that it is time to stop the sacrifice of our children,” she writes, adding:

“Please pray for … the families of all the children who are caught in the middle of what can only be described as a battle between innocent lives and … forces … fueled by the billions of dollars greasing the palms of those who make the decisions about mandatory vaccinations.”

Signs and Symptoms of AFM

With cases of AFM on the rise in the U.S., it’s important to be on the lookout for potential signs and symptoms of AFM, particularly in children. These include:51

Difficulty moving the eyes Facial droop or weakness
Slurred speech Loss of muscle tone
Drooping eyelids Difficulty swallowing
Sudden arm or leg weakness Loss of reflexes

If you notice any of these symptoms, seek medical care immediately as AFM can be life-threatening. The most severe symptom is respiratory failure due to flaccid breathing muscles. In this case, a ventilator may be required. Other neurological complications may also occur, some of which may lead to death.

You cannot find what you refuse to look for

Unfortunately, diagnosis can be difficult, and treatment even more so. According to the CDC:52

“There is no specific treatment for AFM, but a doctor who specializes in treating brain and spinal cord illnesses (neurologist) may recommend certain interventions on a case-by-case basis. For example, neurologists may recommend physical or occupational therapy to help with arm or leg weakness caused by AFM.”

CDC officials state there are few tools for prevention of AFM: “Since we don’t know the cause of most of these AFM cases or what triggers this condition, there is no specific action to take to prevent AFM.”

Unfortunately, unless all of the potential causes of AFM are explored, including provocation polio, which has been linked to acute flaccid paralysis, we may continue to remain in the dark about the cause of this crippling condition for quite some time.
_________________________

For more:

Polio-like disease as been associated with Lyme/MSIDS:

https://madisonarealymesupportgroup.com/2016/11/07/connection-of-acute-flaccid-myelitis-and-vaccinations/  In this article, James Lyons Weiler states:

The US press has been pushing a view of acute flaccid paralysis as a mysterious condition of unknown etiology (unknown cause). Checking the scientific literature, however, tells us that AFP is most often Guillain Barre Syndrome (GBS), a condition that appears on the National Vaccine Injury Compensation Program as a “Table Condition” – i.e., one that the US HHS has no defense against when parents file in the NVICP for compensation for GBS as a vaccine injury in their children.  https://madisonarealymesupportgroup.com/2018/12/07/acute-flaccid-paralysis-is-most-often-guillain-barre-syndrome/

https://madisonarealymesupportgroup.com/2017/07/14/clinical-association-lyme-disease-and-guillain-barre/  In Dr. Waisbren’s book, Treatment of Chronic Lyme Disease, the majority of his 51 cases of chronic Lyme had high EBV titers. He also states,

“As will be seen in other cases, the Epstein-Barr virus may be a candidate for a co-infection associated with LD.”  

Waisbren often treated this co-infected patients that had EBV with 1000mg of Valtrex three times a day with good success.  He also used gamma globulin (4cc twice a week).

https://madisonarealymesupportgroup.com/2017/04/11/diagnosed-with-ebv-had-lyme/

https://madisonarealymesupportgroup.com/2018/04/25/ebv-protein-can-turn-on-genes-for-autoimmune-diseases/

https://madisonarealymesupportgroup.com/2019/01/18/acute-transverse-myelitis-a-clinical-manifestation-of-lyme-that-nobody-has-a-clue-about-prevalence/

https://madisonarealymesupportgroup.com/2019/01/09/transverse-myelitis-guillain-barre-associated-with-bartonella/

https://madisonarealymesupportgroup.com/2018/04/21/neurological-lyme-disease-what-you-need-to-know/  “Once microbes start becoming active, inflammation increases and immune functions are further compromised, establishing what I call Chronic Immune Dysfunction (CID). In its weakened state, the immune system allows reactivation of viruses such as Epstein Barr virus (EBV), Cytomegalovirus (CMV), and other similar viruses — all of which most people harbor in their tissues. These viruses are commonly associated with neuroinflammation, and they tend to complicate the picture of LNB.”

https://madisonarealymesupportgroup.com/2017/11/04/24514/  EBV a Key Player in Chronic Illness & Tips to Treat Reactivated EBV.

Oppose Wisconsin Rule Change to Mandate Meningitis Vaccines & Require Documentation of Chicken Pox Infection

image001

OPPOSE Wisconsin Rule Change to Mandate Meningitis Vaccines and Require Documentation Of Chicken Pox Infection

Submit Comments before 5:00 p.m. Friday 7/26/2019

Attend or Call in to Hearing on Friday7/26 from 8:30-9:30 a.m.

Dear Wisconsin NVIC Advocacy Team Members,

This is a critical action alert for Wisconsin families who care about vaccine choice.

The Wisconsin Department of Health Services is seeking to use the rule making process to increase vaccine mandates for students. This is different from a bill that passes through the legislature, though adopted rules have the same force as law.

If these regulations pass, 7th graders will be required to get a meningitis vaccine and parents will no longer be allowed to confirm that their children had chicken pox, requiring medical personnel to verify it.  These rules are another step toward taking away parental choice in medical decisions for their family and YOUR input is necessary to stop additional government overreach.

The most important way to stop these changes is to SUBMIT PUBLIC COMMENTS OPPOSING the proposed rule change by 5:00 pm on Friday, JULY 26.  It is critical that large numbers of opposition comments are received to stop this rule from passing.

ACTION TO TAKE:

  1. Submit public comments before 5:00 p.m. on Friday 7/26! Talking points below.

Use  web-site form: Select DHS 144 from “Rulemaking Projects” box.

OR

Written comments can be mailed (postmarked by 7/26) or e-mailed by 5:00 p.m. on 7/26:

Susan Uttech

Division of Public Health

Department of Health Services

1 W. Wilson St.

Madison, WI 53703

Email: susan.Uttech@dhs.wisconsin.gov

  1. Attend the public hearing in Madison on 7/26 – testify to oppose the changes.

            Friday, July 26th at 8:30 am-9:30 am.

Conference Room 751

1 Wilson Street

Madison WI  53703 Map 

  1. Call into the hearing to give public comment. Call (608) 316-9000 and use Conference ID: 7313694
  2. Send a copy of this email to your friends and encourage or assist them in writing and submitting public comments.
  3. Please send a copy of your comments to your own state legislators in the house and senate asking them to oppose these rules if they make it to the legislature for approval.  Your legislators can be found HERE:  Enter your address in the web-form.
  4. Continue monitoring the NVIC Advocacy Portal NVICAdvocacy.org to track the status of these rules or other legislation. From here, the Rules will later go before both the House & SenateHealth and Human Services Committees for approval or rejection.  Please save copies of your comments submitted to the department so you can send a copy of your comments to these committee members, with a request that they STOP these Rules when/if they are presented if the health department does not withdraw them.  

DESCRIPTION OF PROPOSED RULES & REASONS TO OPPOSE THEM

  • Proposed changes to Immunization Requirements: HERE.
  • Analysis of the rule and the additional documents: HERE
  • The most recent version of the proposed rule text: HERE.   DHS 144
  • The fiscal estimate and economic impact analysis: HERE.
  • The public hearing notice can be found HERE.

There are several proposed rule changes.  1, 2, 4 and 5 cause the most concern, with 4 and 5 being the most concerning.

1) The Department proposes to change the “substantial outbreak” classification of chicken pox and meningitis.

2) The Department proposes to change the “substantial outbreak” classification of mumps due to mumps outbreaks in “highly-vaccinated populations.”

4) Meningitis vaccine is mandated for 7th grade students.

5) Parents are no longer able to provide confirmation of their children’s case of chicken pox/varicella, requiring a health care provider to now confirm it.

TALKING POINTS:  These are listed in order of importance.  Please use your own words to state your opposition to the proposed changes and include any personal stories that support your concerns.

OPPOSE Proposed Change 4. Meningitis vaccine requirement for 7th graders.

  • There is no urgent public health crisis to justify the expensive and potentially dangerous meningitis vaccine mandate for all Wisconsin 7th graders.
  • Meningitis is very rare in the United States, with the CDC reporting a total of only 350 cases in 2017.  The 2017 US population of approximately  325.7 million, meant that 1 in 931,000 people got meningitis and 1 in 7.2 million died.  Of the 45 deaths, ONLY 14 cases were in the age group 0-23.  These numbers do NOT indicate a public health crisis.  The mandate is unnecessary.
  • Meningococcal vaccine is currently available to any family who wants it.
  • According to the CDC, Wisconsin recorded only 6 meningococcal cases in 2016 and 4 cases in 2017. The state records are slightly different, yet, in 2015, there were only 3 cases in the 14-23 age group, with one of those being in college or technical school.
  • The vaccine only has an 80-85% efficacy rate. After two years to five years, the vaccine has been found to be, at best, only about 58 percent effective. Due to the  vaccine’s effectiveness waning, the only recommendation is that ADDITIONAL vaccines be given.
  • The package inserts for meningitis vaccines, Menactra and Menveo, indicate that   “serious adverse events” occur in 1 percent of recipients.
  • According to the CDC Pink Book, 0.3 percent of those with “serious adverse events” from meningitis vaccines will die.
  • If approximately 63,000 7th graders are given the Menactra or Menveo meningitis vaccines, Wisconsin can reasonably expect 630 serious adverse events and possibly 2 (1.89) deaths.
  • This is significant since the 2015 Wisconsin data only shows 2 cases of meningitis in high school age students with NO deaths.
  • The federal Vaccine Adverse Events Reporting System (VAERS), which includes only a small fraction of the health problems that occur after vaccination in the U.S., reports 32,453 adverse events as of July 2019.  Of these, 3,955 were considered serious and there were 186 deaths, with 90 of those being in children under 17 years of age. www.medalerts.org
  • The meningitis vaccines contain neurotoxins such as formaldehyde, aluminum hydroxide, polysorbate 80, and thimerosal, a mercury derivative.
  • Meningitis vaccines list documented side effects including death, anaphylaxis/anaphylactic reaction, difficulty breathing, upper airway swelling, Guillain-Barré syndrome, dizziness, convulsion, acute disseminated encephalomyelitis, irritability, abnormal crying, fever, drowsiness, fatigue, injection site pain and swelling, sudden loss of consciousness (syncope), diarrhea, headache, joint pain, brain inflammation, and facial palsy.   Bexsero,  Menveo,Menomune, Menactra

OPPOSE Proposed Change 5. Parental reporting of chicken pox will no longer be acceptable.  Instead, a health care provider must confirm infection.

  • It is irresponsible of the Department to insist that a child with a highly contagious, yet often a generally mild disease, visit a medical facility where other children, including those who are medically fragile, will likely be present and thus at higher risk to contract it and become one of the rare adverse outcomes.
  • Not all families have existing relationships with the list of specified medical workers, and this provision could force a family to enter into a new unwanted contractual relationship with unknown medical staff.
  • Most families will also have the financial burden of all charges, or co-pays as well as laboratory fees.
  • This change would create an environment of distrust between the school staff and the parents as the parents’ word is questioned.
  • There is no provision for a titer test to be used as proof.

The Department’s claims of “little to no economic impact” in their justification for the rule change doesn’t reflect the strong negative economic impact on Wisconsin Families

  • Wisconsin families will be required to pay for doctor visits and vaccine costs to receive newly mandated vaccines.
  • The annual cost for approximately 63,000 Wisconsin 7th graders to receive meningitis vaccines will be over $10.7 million as the CDC vaccine price list for Bexsero shows the private sector cost at $170/dose.  Add in office visit expenses and there is little doubt why there is significant support for this vaccine by those who gain financially for its mandated use.
  • Requiring Wisconsin families to pay for doctor visit to have chicken pox verified will be expensive.  For generations, many families have treated chicken pox at home, as it is generally mild.  Arranging an office visit for a case of the chicken pox would add drastically to the economic impact on the families of a sick child.

OPPOSE Proposed Change 2. Change the “substantial outbreak” classification of mumps

  • The mumps component of the MMR used in the US has been the subject of a federal whistleblower fraud suit since 2010.  Two manufacturer (Merck) virologists claimed they were forced to create fraudulent efficacy results by adding rabbit antibodies so that the vaccine could remain on the CDC schedule and Merck could retain its monopoly.
  • The reason for this change is due to mumps outbreaks in “highly-vaccinated populations,” showing the vaccine’s ineffectiveness.  A few years, 1676 Arkansas school age children had mumps and 1536 (92%) had previously received at least two doses of a vaccine containing the mumps virus.  A recent mumps outbreak amongst  100% vaccinated Navy sailors on the USS Ft. McHenry, kept it in quarantine for over 5 months.
  • The Health Department should educate families on the risks of catching mumps and how to treat it due to an ineffective vaccine.

OPPOSE Proposed Change 1. Change the “substantial outbreak” to include meningitis and chicken pox. OPPOSE the inclusion of chicken pox in the “substantial outbreak” classification due to it generally being a mild infection that can be treated at home.

OPPOSE Department’s lack of notifying the public, the MAIN STAKEHOLDER, when publishing these proposed rules changes.

  • The Department claims they contacted all stakeholders which would be impacted by the proposed rule including, “Schools, school-aged children and parents, school boards, and public and private health care providers.”
  • Parents were not included as stakeholders, neither were they adequately informed.  The Department’s effort to inform the primary stakeholder, parents of school age children, was completely inadequate.  If not for the attention by watch dog groups, this rule would be implemented without parents knowing of their ability to participate in the process to oppose it.
  • Using the Rule process to change vaccine mandates removes the process from legislators who are accountable to their voting constituents.

Sincerely,

NVIC Advocacy Team
National Vaccine Information Center
http://NVIC.org and http://NVICAdvocacy.org
https://nvicadvocacy.org/members/Members/ContactUs.aspx

The National Vaccine Information Center (NVIC) works diligently to prepare and disseminate our legislative advocacy action alerts and supporting materials.  We request that organizations and members of the public forward our alerts in their original form to assure consistent and accurate messaging and effective action. Please acknowledge NVIC as originators of this work when forwarding to members of the public and like-minded organizations. To receive alerts immediately, register  at http://NVICAdvocacy.org, a website dedicated to this sole purpose and provided as a free public service by NVIC. 

Lyme Disease Vaccines: Past & Future

https://thevaccinereaction.org/2019/07/lyme-disease-vaccines-past-and-future/

Lyme Disease Vaccines: Past and Future

Lyme Disease Vaccines: Past and Future

STORY HIGHLIGHTS

  • A new Lyme disease vaccine candidate approved by the FDA using the fast track process is currently in its second phase of clinical trials.
  • In 1998, the FDA granted licensure for a Lyme disease vaccine called LYMErix.
  • Following reports of severe adverse reactions to LYMErix, GlaxoSmithKline (formerly SmithKline Beecham) withdrew the vaccine from the market in 2002.

Lyme disease is an infection caused by a bacterium known as Borrelia burgdorferi and is transmitted to humans through infected ticks. Typical symptoms include fever, headaches, fatigue and a characteristic skin rash called erythema migrans. In 2017, there were a total of 42,743 confirmed and probable cases of Lyme disease reported to the Centers for Disease Control and Prevention (CDC)—an increase of more than 17 percent since 2016.1 2

There are currently no vaccines for Lyme disease available for humans in the United States. However, there is a new vaccine candidate in the pipeline now in clinical trials.

In 2017, the U.S. Food and Drug Administration (FDA) approved a Fast Track designation for a new Lyme disease vaccine. The goal of the Fast Track designation is to get the vaccine on the market as soon as possible by lowering the bar for proof of safety and efficacy in favor of speeding up the licensing process. When an experimental is designated by the FDA for Fast Track approval, the FDA will accept less data from the manufacturer pre-licensure and allow ongoing post-marketing clinical studies after licensure approval.3 4 5

French biotech company Valneva has announced  the initiation of the second study of Phase 2 clinical development for its Lyme disease vaccine candidate, VLA15. VLA15 is a multivalent, protein subunit vaccine that targets the outer surface protein A (OspA) of Borrelia.The goal of Phase 2 is to determine the optimal dosage level and vaccination schedule for its use in Phase 3 efficacy studies.5 6

The Phase 2 study is a randomized, observer-blind, placebo controlled trial conducted at sites in the U.S. where Lyme disease is endemic. Plans call for 250 people to receive one of two doses of VLA15 (100 people each) or placebo (50 people). The vaccine candidate contains aluminum adjuvants and will be injected intramuscularly at day 1, day 57 and day 180. The participants in the study will be monitored for 18 months immunogenicity will be measured at day 208. The clinical trial participants will include healthy adults between the ages of 18 and 65.5

The LYMErix Debacle

VLA15 is not the first Lyme disease vaccine to be developed. In December 1998, the FDA approved a recombinant Lyme disease vaccine known as LYMErix that was manufactured by SmithKline Beecham (now GlaxoSmithKline). LYMErix was a three-dose vaccine that was believed to be 49 to 68 percent effective at preventing Lyme disease with two doses and 76 to 92 percent effective after the third dose.6 7

As a result of concerns regarding the potential safety of the vaccine prior to its licensure, an FDA panel met in May 1998 to review the proposed LYMErix vaccine. The panel acknowledged that there were several safety concerns regarding the vaccine, one of which was its possible relationship to autoimmune arthritis. The panel was concerned that the vaccine could result in inflammatory arthritis in genetically susceptible patients. This concern was raised during a clinical study in which vaccine subjects reported a greater number of transient arthralgias than the placebo subjects. Despite the glaring concerns, the FDA panel gave its unanimous support for the vaccine’s licensure.7 8

Soon after the vaccine was licensed in the U.S, there was a burst of media coverage around Lyme disease and LYMErix. The vaccine received prime time media coverage, with news reports highlighting the benefits of the vaccine but with almost no mention of the potential risks associated with the vaccine. The media encouraged those living in endemic areas to consult their health professionals about getting the vaccine.8 9

By 1999, LYMErix was receiving more negative than positive publicity. There were reports of serious adverse reactions occurring after vaccination. Although there was a wide range of adverse reactions reported, musculoskeletal complaints such as arthritis were the most common in these reports. The media began reporting experiences of vaccine injured victims and the Lyme Disease Network, a non-profit citizen action group, had extensive website coverage about serious reactions to LYMErix.8

In December 1999, the Philadelphia law firm of Sheller, Ludwig & Bailey filed a class action lawsuit against the LYMErix™ manufacturer, SmithKline Beecham. The law firm represented 121 individuals who claimed that they experienced severe adverse reactions to LYMErix. The suit claimed that the vaccine caused harm and that the manufacturer deliberately concealed evidence about its risks and failures.8

As a result of lawsuits and public outcry at a Jan. 31, 2001 meeting of the FDA Vaccines & Related Biological Products Advisory Committee (VRBPAC), the committee discussed evidence for safety concerns about LYMErix and held a two-hour public comment session. Participants at the meeting included FDA scientific advisors, representatives from SmithKline Beecham, physicians, consumer advocacy organizations, vaccine injured victims and their lawyers.8 10

The FDA advisory committee reviewed a summary of the Vaccine Adverse Event Reporting System (VAERS) data and concluded that there was no causal relationship between LYMErix and inflammatory arthritis. SmithKline Beecham assured the panel that LYMErix was safe and provided a status review of their Phase 4 post-marketing surveillance. Physicians spoke about the effectiveness of the vaccine, noting a dramatic decline of Lyme disease in their clinical practices.8

There were other scientists at the meeting, however, who argued that the vaccine could indeed trigger OspA-autoimmunity in those patients who had a genetic susceptibility. Vaccine injured victims described their suffering and their lawyers said that the manufacturer deliberately failed to provide warnings about increased reaction risks for genetically susceptible patients.8

The FDA Committee, however, decided that the benefits of LYMErix outweighed its risks. No changes were made to the product’s labeling or indications. The FDA requested that the manufacturer provide more vaccine and efficacy data by increasing the number of subjects in the Phase 4 post-marketing trial. The vaccine remained on the market for public use.8

Due to the negative press coverage and publicity about the vaccine risks and lawsuits, the sales for LYMErix dropped significantly. In 2001, the manufacturer  reported $5 million in sales with the purchase of only 93,000 doses of the vaccine. In February 2002, GlaxoSmithKline (GSK) decided to withdraw the vaccine from the market citing poor market performance.7 8

In July 2003, GSK settled the class action lawsuit with Sheller, Ludwig & Bailey and other smaller law firms. The agreement included $1 million for legal fees for the prosecuting attorneys but no compensation for the vaccine injured victims. The prosecuting attorneys expressed that the voluntary withdrawal of the vaccine from the market was the main intention of the lawsuit.8

According to a report published in Epidemiology & Infection:

“Despite the settlement, the manufacturer continued to deny that LYMErix™ caused harm and indicated that the decision to settle represented a choice based on economic concerns (i.e. the desire to avoid the costs of lengthy litigation) for a product showing relatively poor performance in the market.”8


References:

_________________

**Comment**

Deny, deny, deny…..that’s what authorities have been doing for decades on pretty much everything regarding Lyme/MSIDS.

https://madisonarealymesupportgroup.com/2018/07/01/lyme-vaccine-fail-safety-ignored/

https://madisonarealymesupportgroup.com/2018/06/07/the-lyme-vaccine-russian-roulette/

https://madisonarealymesupportgroup.com/2018/06/06/valneva-seeking-partner-for-350m-lyme-disease-vaccine-effort-prepping-for-phase-2/  (Please read my comment after the article.  This is far from a benign vaccine.  It has caused outright harm – even death)

https://madisonarealymesupportgroup.com/2017/07/01/pbs-lyme-vaccine/  Did you know that the LYMERIX vaccine caused 640 emergency room visits, 34 life threatening reactions, 77 hospitalizations, 198 disabilities, and 6 deaths? In a vile cesspool of conflicts of interest are university patent holders, drug companies, and the FDA itself as another patent holder. It generated 40 million dollars before it was yanked. (2008, Drymon)
As you can see in Dr. Lapenta’s article, the death toll raised to 229.  https://madisonarealymesupportgroup.com/2018/01/28/the-secret-x-files-the-untold-history-of-the-lymerix-vaccine/

Besides, death and suicide, please see:
http://www.yourlawyer.com/topics/overview/lymerix One doctor stated that 21 patients developed severe arthritis after receiving the LYMERIX vaccine.

http://www.lymediseaseassociation.org/index.php/about-lyme/controversy/vaccine/261-lymerix-meeting

“Given that Dr. Marks lead the clinical trials for Lymerix’s competitor, the OspA vaccine produced and then abandoned by Aventis Pasteur, his conclusions mean a lot. “In my opinion,” he told FDA officials, “there is sufficient evidence that Lymerix is causally related to severe rheumatologic, neurologic, autoimmune, and other adverse events in some individuals. This evidence is such as to warrant a significantly heightened degree of warnings and possible limitations or removal from marketing of Lymerix.”

Another glaring issue about the Lyme vaccine is it only covers borrelia, the causative agent of Lyme when often there are many other pathogens involved. These pathogens work synergistically together to depress the immune system. Vaccines also depress the immune system purposely to initiate an immune response. Nobody is discussing what the two together do inside the human body, but logic would state it can’t be good:  https://madisonarealymesupportgroup.com/2018/10/30/study-shows-lyme-msids-patients-infected-with-many-pathogens-and-explains-why-we-are-so-sick/

Every single Lyme/MSIDS patient I work with that gets vaccinated suffers a relapse.

This doctor shows vaccines reactive latent infections:  https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-on-lyme-msids-part-2/

https://madisonarealymesupportgroup.com/2016/04/24/gardasil-and-bartonella/

Then there’s the little known fact that there has been a history of retroviral contamination of vaccines:  https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/

These retroviruses are connected to chronic diseases according to a well known Lyme literate doctor:  https://madisonarealymesupportgroup.com/2018/06/23/the-role-of-retroviruses-in-chronic-illness-a-clinicians-perspective/

CDC Admits Flu Vaccine Failed 91% of the Time Against Current Flu Strain

https://thefreethoughtproject.com/flu-vaccine-9-percent-effective-cdc/

flu vaccine

CDC Admits Flu Vaccine Failed 91% of the Time Against Current Flu Strain

The latest numbers from the CDC on the flu vaccine show that this year’s shots were only 9% effective against the current strain that popped up mid-season.

Every year, the Centers for Disease Control releases its data on how effective the flu vaccine has been for the previous season, and nearly every year, the numbers are disappointing. Once again, doctors are now expressing their disappointment over the latest flu vaccine with the release of the CDC’s new data.

This year’s flu vaccine “failed miserably” according to the CDC due to a current flu strain that showed up halfway through the season.

As ABC 7 reports, in fact — the agency rated its effectiveness at just 9% against that strain and the overall effectiveness for the entire season at 29%.

And this is the case nearly every year. Despite this terrible track record of not working, every year, the CDC continues to urge everyone to get the flu shot. What’s more, according to ABC News, vaccines against most infectious diseases are not considered successful unless they are at least 90% effective. Due to the flu virus’ ability to change so quickly, vaccine effectiveness usually averages around 40%.

Since the United States has never seen a 90% effective rate, the flu vaccine has never been considered successful.

In spite of this fact, municipalities across the country enact laws to ban children and adults alike from schools and workplaces unless they receive the flu vaccine.

As TFTP reported earlier this year, Connecticut parents were told that if they cannot prove their child received the flu vaccine, they will not be allowed to return to school.

The new state law is simple: comply or your child cannot go to school.

Lawmakers claim that the laws like these are necessary because every year in the US roughly 20,000 children under 5 are hospitalized because of the flu. But historically, the data shows that these numbers are largely skewed.

The CDC has been telling the public for nearly a decade that there are more than 200,000 estimated hospitalizations and 36,000 estimated deaths from influenza in the U.S. every year.

But these estimates count a lot of people hospitalized – not just with influenza but also with pneumonia, respiratory and circulatory illnesses – which they counted as probably associated with influenza.

What’s more is the fact that the flu shot is a crap shoot every year. It was no secret that like this year, last year’s vaccine was all but entirely ineffective. 

Also, despite reassurance from government officials, the flu vaccine has been documented to cause harm.

As TFTP reported in December, Shane Morgan, like millions of other Americans was vaccinated against the flu virus in November. However, within 36 hours of receiving the shot, he began experiencing symptoms of the flu.

“About 36 hours after he got the flu shot he started to get sick,” said Mr. Morgan’s wife, Monique.

After staying in bed for a week at his house, Morgan did not improve. In fact, things got far worse and he had to be admitted to the emergency room ICU.

Morgan spent the next 3 weeks in the ICU, blinded and paralyzed. He is now home with his family but he is far from back to normal as he’s still partially blind and in a wheelchair.

_________________

**Comment**

So much for being “safe.”

More on the flu-vaccine:

https://madisonarealymesupportgroup.com/2018/10/21/woman-undergoes-extensive-arm-surgery-after-flu-shot/

https://madisonarealymesupportgroup.com/2017/03/30/ty-bollinger-the-truth-about-vaccines-series/

Great read on all aspects of the flu-vaccine:  https://www.nvic.org/Vaccines-and-Diseases/Influenza.aspx

The CDC reported in February 2018 that between 2004/2005 and 2017/2018, the influenza vaccine was less than 50 percent effective in ten out of 14 flu seasons. In the 2014-2015 flu season, the influenza vaccine was only 19 percent effective.4

A 2018 Cochrane Collaboration published a review of medical literature on the effects of the influenza vaccination in the elderly and concluded that:

“The available evidence relating to complications is of poor quality, insufficient, or old and provides no clear guidance for public health regarding the safety, efficacy, or effectiveness of influenza vaccines for people aged 65 years or older.”9

The Cochrane review also concluded that recommendations for routine use of influenza vaccine as a routine public health measure was not supported by the published evidence base and stated,

“The results of this review provide no evidence for the utilisation of vaccination against influenza in healthy adults as a routine public health measure. As healthy adults have a low risk of complications due to respiratory disease, the use of the vaccine may only be advised as an individual protective measure.” 13

https://madisonarealymesupportgroup.com/2018/10/23/influenza-vaccines-dengue-like-disease/  Excerpt:

When a person making anti-H3N2 IgE is infected with H3N2, one can expect the course of the flu to be significantly worse. So the “cytokine storm” being observed in severe cases is likely to be an infection concurrent with an allergic reaction. Death is caused by anaphylactic shock but due to the presence of an infection, it is wrongly classified as septic shock.

I post information about vaccines for many reasons – but one of the largest reasons is because they have caused relapses in Lyme/MSIDS patients as well as activated latent infections: https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-gives-insight-on-lyme-msids/

https://madisonarealymesupportgroup.com/2016/04/24/gardasil-and-bartonella/Excerpt: 

There is further damning evidence that Gardasil can produce life-threatening reactions in those who have been close to a cat, fleas, or ticks, since many of these animals are infected with Bartonella, Babesia, or Lyme (borrelia). Also, since many MSIDS patients (multi systemic infectious disease syndrome) also struggle with viruses such as Mono or active EBV, a cytokine storm can resultwith mucus being over manufactured in lungs and airways and well as wide-spread inflammation.

Asymptomatic girls after receiving Gardasil activated dormant Bartonella which was confirmed by testing.

“Gardasil contains aluminum adjuvant nano-prticle substrates, bound to HPV16-L1 protein fragments, that appear to have mutated at binding sites, possibly resulting in excessive inflammation. The mutation attaches to the endothelial lining of blood vessels and organs, including the brain, if the host lacks sufficient active glutathione, or similar complimentary attractant, or does not readily clear toxins. Inflammatory HPV16-L1 DNA protein particles were found in autopsy tissue samples from two different teenage girls, six months after receiving her last vaccination, in the case of one deceased girl. Our findings indicate that if the blood brain barrier is open, commonly due to allergies or the common cold, these man-made inflammatory vaccine nano-particles may enter the brain, and cause additional damage, and possible demyelination.”

Statistics indicate that 50% of domestic cats in the US are infected with Bartonella, and humans can contract Bartonella and have no symptoms at all. It can lie dormant until a stressor, such as a vaccine, triggers an active infection.

MMR Vaccine Licensing Called into Question Following ICAN’s Latest FOIA Exposure of FDA Coverup

https://www.prnewswire.com/news-releases/mmr-vaccine-licensing-called-into-question-following-icans-latest-foia-exposure-of-fda-coverup-300842503.html

MMR Vaccine Licensing Called Into Question Following ICAN’s Latest FOIA Exposure of FDA Coverup


AUSTIN, Texas, May 2, 2019 /PRNewswire/ — In another significant legal win for vaccine risk awareness non-profit Informed Consent Action Network (ICAN), a new Freedom of Information Act disclosure from the Federal Food and Drug Administration (FDA) has revealed that the MMR vaccine was licensed based on clinical trials which in total had less than 1,000 participants and far more adverse reactions than previously acknowledged.

“It’s alarming that an appeal was required to get this information, but it’s more alarming that every time ICAN prevails in obtaining a FOIA disclosure from the FDA, CDC or HHS, we learn about another serious shortcoming in their duties to assure Americans’ health and health care,” says Del Bigtree, ICAN founder and host of the weekly fact-based medical news show “The HighWire.”

The MMR vaccine is at the heart of the vaccine debate. The following are some of the key facts learned from the clinical trial reports produced by the FDA, which the agency relied upon to license the MMR:

  • There were eight clinical trials that in total had less than 1,000 individuals, out of which only 342 children received the MMR vaccine
  • The safety review period only tracked ‘adverse events’ for 42 days after injection
  • More than half or a significant percent of all participants in each of the eight trials developed gastrointestinal symptoms and upper respiratory infections
  • All adverse events were generically described as ‘other viruses’ and not considered in safety profile of licensure
  • The control group received other vaccines for either rubella or measles and rubella, and none of the controls received a placebo (an inert substance such as a saline injection)

Bigtree, an Emmy-Award winning producer, and director of the documentary “Vaxxed: From Coverup to Catastrophe,” says the reason for increased vaccine hesitancy is not unreasonable fear, but a growth in awareness of the corruption, secrecy and obvious overt propaganda surrounding vaccines and the pharmaceutical industry.

“Thanks to the laws in this country that for now at least permit access to various government records, we now know the MMR vaccine was licensed using an irresponsibly small and limited group of children,” says Bigtree.

“But what’s even more alarming is learning about the serious adverse events that were known and acknowledged, yet ignored in order to license the MMR vaccine,” Bigtree adds, noting “This was after only tracking adverse events for 42 days after injection – imagine what they might have found had they tracked safety for three years against an appropriate control, like they do for drugs.”

SOURCE Informed Consent Action Network

___________________

For more on the MMR vaccine:  https://madisonarealymesupportgroup.com/2019/03/06/genetic-sequencing-science-breakthrough-just-proved-that-measles-outbreaks-are-caused-by-the-measles-vaccine/

https://madisonarealymesupportgroup.com/2019/04/20/a-scientists-rebuttal-to-the-danish-cohort-study-on-the-mmr-vaccine/

https://madisonarealymesupportgroup.com/2019/06/13/blast-from-the-past-cdc-vaccine-authors-destroy-evidence-of-vaccine-harm/

https://madisonarealymesupportgroup.com/2018/10/18/lawfirm-announces-101-million-measles-vaccine-settlement-for-infant-that-suffered-brain-injury/

https://madisonarealymesupportgroup.com/2019/02/01/cnn-forced-to-correct-piece-on-measles/

https://madisonarealymesupportgroup.com/2018/10/27/measles-transmitted-by-the-vaccinated-gov-researchers-confirm/

 

More on Measles: https://madisonarealymesupportgroup.com/2019/06/03/what-is-going-on-with-measles-the-science-politics-of-eradicating-measles/

https://madisonarealymesupportgroup.com/2019/03/15/medical-doctor-of-50-years-current-measles-hysteria-not-based-on-science-but-scientism-a-quasi-religious-faith-in-vaccines/

https://madisonarealymesupportgroup.com/2019/04/03/sierra-avenue-school-exposed-to-measles-after-vaccinated-teacher-contracts-illness/

https://madisonarealymesupportgroup.com/2019/03/21/measles-propaganda-can-have-dire-public-health-ramifications/